J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
This digital linking of individual’s health records with ABHA is being carried out extensively across different health facilities of the country
Positive opinions based on significant survival benefit
This combination has the potential to be the first treatment option combining an antibody-drug conjugate plus an immunotherapy in this treatment setting
Post the sale, Patel family has become the single largest promoter shareholder in the company
Subscribe To Our Newsletter & Stay Updated
